EMEA (Europe, Middle East and Africa) Cancer Treatment Drugs Market Report 2018

January 2018 | 129 pages | ID: E7D353F97BCEN
QYResearch

Abstracts

In this report, the EMEA Cancer Treatment Drugs market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Cancer Treatment Drugs for these regions, from 2013 to 2025 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Cancer Treatment Drugs market competition by top manufacturers/players, with Cancer Treatment Drugs sales volume (K MT), price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Roche (Switzerland)
• Novartis (Switzerland)
• Celgene (U.S.)
• Amgen (U.S.)
• Johnson & Johnson (U.S.)
• Bristol-Myers Squibb (U.S.)
• Takeda (Japan)
• Eli Lilly (U.S.)
• Pfizer (U.S.)
• AstraZeneca (Sweden)
• Astellas (Japan)
• Sanofi (France)
• Bayer (Germany)
• Merck & Co. (U.S.)
• Biogen Idec (U.S.)
• Kyowa Hakko Kirin (Japan)
• Otsuka (Japan)
• Teva (Israel)
• Eisai (Japan)
• Merck KGaA (Germany)
• Ipsen (France)
• AbbVie (U.S.)
• Gilead Sciences (U.S.)

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Chemotherapy
• Targeted Therapy
• Immunotherapy
• Hormonal Therapy (Biologic Therapy)
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Blood Cancer
• Breast Cancer
• Gastrointestinal Cancer
• Prostate Cancer
• Respiratory/Lung Cancer
• Other Cancers

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Cancer Treatment Drugs Market Report 2018

1 CANCER TREATMENT DRUGS OVERVIEW

1.1 Product Overview and Scope of Cancer Treatment Drugs
1.2 Classification of Cancer Treatment Drugs
  1.2.1 EMEA Cancer Treatment Drugs Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 EMEA Cancer Treatment Drugs Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 Chemotherapy
  1.2.4 Targeted Therapy
  1.2.5 Immunotherapy
  1.2.6 Hormonal Therapy (Biologic Therapy)
  1.2.7 Others
1.3 EMEA Cancer Treatment Drugs Market by Application/End Users
  1.3.1 EMEA Cancer Treatment Drugs Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.2 Blood Cancer
  1.3.3 Breast Cancer
  1.3.4 Gastrointestinal Cancer
  1.3.5 Prostate Cancer
  1.3.6 Respiratory/Lung Cancer
  1.3.7 Other Cancers
1.4 EMEA Cancer Treatment Drugs Market by Region
  1.4.1 EMEA Cancer Treatment Drugs Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 Europe Status and Prospect (2013-2025)
  1.4.3 Middle East Status and Prospect (2013-2025)
  1.4.4 Africa Status and Prospect (2013-2025)
1.5 EMEA Market Size (Value and Volume) of Cancer Treatment Drugs (2013-2025)
  1.5.1 EMEA Cancer Treatment Drugs Sales and Growth Rate (2013-2025)
  1.5.2 EMEA Cancer Treatment Drugs Revenue and Growth Rate (2013-2025)

2 EMEA CANCER TREATMENT DRUGS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Cancer Treatment Drugs Market Competition by Players/Manufacturers
  2.1.1 EMEA Cancer Treatment Drugs Sales Volume and Market Share of Major Players (2013-2018)
  2.1.2 EMEA Cancer Treatment Drugs Revenue and Share by Players (2013-2018)
  2.1.3 EMEA Cancer Treatment Drugs Sale Price by Players (2013-2018)
2.2 EMEA Cancer Treatment Drugs (Volume and Value) by Type/Product Category
  2.2.1 EMEA Cancer Treatment Drugs Sales and Market Share by Type (2013-2018)
  2.2.2 EMEA Cancer Treatment Drugs Revenue and Market Share by Type (2013-2018)
  2.2.3 EMEA Cancer Treatment Drugs Sale Price by Type (2013-2018)
2.3 EMEA Cancer Treatment Drugs (Volume) by Application
2.4 EMEA Cancer Treatment Drugs (Volume and Value) by Region
  2.4.1 EMEA Cancer Treatment Drugs Sales and Market Share by Region (2013-2018)
  2.4.2 EMEA Cancer Treatment Drugs Revenue and Market Share by Region (2013-2018)
  2.4.3 EMEA Cancer Treatment Drugs Sales Price by Region (2013-2018)

3 EUROPE CANCER TREATMENT DRUGS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Cancer Treatment Drugs Sales and Value (2013-2018)
  3.1.1 Europe Cancer Treatment Drugs Sales Volume and Growth Rate (2013-2018)
  3.1.2 Europe Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
3.2 Europe Cancer Treatment Drugs Sales and Market Share by Type
3.3 Europe Cancer Treatment Drugs Sales and Market Share by Application
3.4 Europe Cancer Treatment Drugs Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Cancer Treatment Drugs Sales Volume by Countries (2013-2018)
  3.4.2 Europe Cancer Treatment Drugs Revenue by Countries (2013-2018)
  3.4.3 Germany Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
  3.4.4 France Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
  3.4.5 UK Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
  3.4.6 Russia Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
  3.4.7 Italy Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
  3.4.8 Benelux Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

4 MIDDLE EAST CANCER TREATMENT DRUGS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Cancer Treatment Drugs Sales and Value (2013-2018)
  4.1.1 Middle East Cancer Treatment Drugs Sales Volume and Growth Rate (2013-2018)
  4.1.2 Middle East Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
4.2 Middle East Cancer Treatment Drugs Sales and Market Share by Type
4.3 Middle East Cancer Treatment Drugs Sales and Market Share by Application
4.4 Middle East Cancer Treatment Drugs Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Cancer Treatment Drugs Sales Volume by Countries (2013-2018)
  4.4.2 Middle East Cancer Treatment Drugs Revenue by Countries (2013-2018)
  4.4.3 Saudi Arabia Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
  4.4.4 Israel Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
  4.4.5 UAE Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
  4.4.6 Iran Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

5 AFRICA CANCER TREATMENT DRUGS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Cancer Treatment Drugs Sales and Value (2013-2018)
  5.1.1 Africa Cancer Treatment Drugs Sales Volume and Growth Rate (2013-2018)
  5.1.2 Africa Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
5.2 Africa Cancer Treatment Drugs Sales and Market Share by Type
5.3 Africa Cancer Treatment Drugs Sales and Market Share by Application
5.4 Africa Cancer Treatment Drugs Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Cancer Treatment Drugs Sales Volume by Countries (2013-2018)
  5.4.2 Africa Cancer Treatment Drugs Revenue by Countries (2013-2018)
  5.4.3 South Africa Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
  5.4.4 Nigeria Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
  5.4.5 Egypt Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
  5.4.6 Algeria Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

6 EMEA CANCER TREATMENT DRUGS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Roche (Switzerland)
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Cancer Treatment Drugs Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Roche (Switzerland) Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Novartis (Switzerland)
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Cancer Treatment Drugs Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Novartis (Switzerland) Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Celgene (U.S.)
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Cancer Treatment Drugs Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Celgene (U.S.) Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Amgen (U.S.)
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Cancer Treatment Drugs Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Amgen (U.S.) Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Johnson & Johnson (U.S.)
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Cancer Treatment Drugs Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Johnson & Johnson (U.S.) Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Bristol-Myers Squibb (U.S.)
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Cancer Treatment Drugs Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Bristol-Myers Squibb (U.S.) Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Takeda (Japan)
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Cancer Treatment Drugs Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Takeda (Japan) Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Eli Lilly (U.S.)
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Cancer Treatment Drugs Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Eli Lilly (U.S.) Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Pfizer (U.S.)
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Cancer Treatment Drugs Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Pfizer (U.S.) Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 AstraZeneca (Sweden)
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Cancer Treatment Drugs Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 AstraZeneca (Sweden) Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 Astellas (Japan)
6.12 Sanofi (France)
6.13 Bayer (Germany)
6.14 Merck & Co. (U.S.)
6.15 Biogen Idec (U.S.)
6.16 Kyowa Hakko Kirin (Japan)
6.17 Otsuka (Japan)
6.18 Teva (Israel)
6.19 Eisai (Japan)
6.20 Merck KGaA (Germany)
6.21 Ipsen (France)
6.22 AbbVie (U.S.)
6.23 Gilead Sciences (U.S.)

7 CANCER TREATMENT DRUGS MANUFACTURING COST ANALYSIS

7.1 Cancer Treatment Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Cancer Treatment Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Cancer Treatment Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Cancer Treatment Drugs Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA CANCER TREATMENT DRUGS MARKET FORECAST (2018-2025)

11.1 EMEA Cancer Treatment Drugs Sales, Revenue and Price Forecast (2018-2025)
  11.1.1 EMEA Cancer Treatment Drugs Sales and Growth Rate Forecast (2018-2025)
  11.1.2 EMEA Cancer Treatment Drugs Revenue and Growth Rate Forecast (2018-2025)
  11.1.3 EMEA Cancer Treatment Drugs Price and Trend Forecast (2018-2025)
11.2 EMEA Cancer Treatment Drugs Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.3 Europe Cancer Treatment Drugs Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.4 Middle Eastt Cancer Treatment Drugs Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.5 Africa Cancer Treatment Drugs Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.6 EMEA Cancer Treatment Drugs Sales Forecast by Type (2018-2025)
11.7 EMEA Cancer Treatment Drugs Sales Forecast by Application (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Cancer Treatment Drugs
Figure EMEA Cancer Treatment Drugs Sales Volume (K MT) by Type (2013-2025)
Figure EMEA Cancer Treatment Drugs Sales Volume Market Share by Type (Product Category) in 2017
Figure Chemotherapy Product Picture
Figure Targeted Therapy Product Picture
Figure Immunotherapy Product Picture
Figure Hormonal Therapy (Biologic Therapy) Product Picture
Figure Others Product Picture
Figure EMEA Cancer Treatment Drugs Sales Volume (K MT) by Application (2013-2025)
Figure EMEA Sales Market Share of Cancer Treatment Drugs by Application in 2017
Figure Blood Cancer Examples
Table Key Downstream Customer in Blood Cancer
Figure Breast Cancer Examples
Table Key Downstream Customer in Breast Cancer
Figure Gastrointestinal Cancer Examples
Table Key Downstream Customer in Gastrointestinal Cancer
Figure Prostate Cancer Examples
Table Key Downstream Customer in Prostate Cancer
Figure Respiratory/Lung Cancer Examples
Table Key Downstream Customer in Respiratory/Lung Cancer
Figure Other Cancers Examples
Table Key Downstream Customer in Other Cancers
Figure EMEA Cancer Treatment Drugs Market Size (Million USD) by Region (2013-2025)
Figure Europe Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Cancer Treatment Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Middle East Cancer Treatment Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Africa Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Africa Cancer Treatment Drugs Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Cancer Treatment Drugs Sales Volume and Growth Rate (2013-2025)
Figure EMEA Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure EMEA Cancer Treatment Drugs Market Major Players Product Sales Volume (K MT) (2013-2018)
Table EMEA Cancer Treatment Drugs Sales Volume (K MT) of Major Players (2013-2018)
Table EMEA Cancer Treatment Drugs Sales Share by Players (2013-2018)
Figure 2017 Cancer Treatment Drugs Sales Share by Players
Figure 2017 Cancer Treatment Drugs Sales Share by Players
Figure EMEA Cancer Treatment Drugs Market Major Players Product Revenue (Million USD) (2013-2018)
Table EMEA Cancer Treatment Drugs Revenue (Million USD) by Players (2013-2018)
Table EMEA Cancer Treatment Drugs Revenue Share by Players (2013-2018)
Table 2017 EMEA Cancer Treatment Drugs Revenue Share by Players
Table 2017 EMEA Cancer Treatment Drugs Revenue Share by Players
Table EMEA Cancer Treatment Drugs Sale Price (USD/MT) by Players (2013-2018)
Table EMEA Cancer Treatment Drugs Sales (K MT) and Market Share by Type (2013-2018)
Table EMEA Cancer Treatment Drugs Sales Share by Type (2013-2018)
Figure Sales Market Share of Cancer Treatment Drugs by Type (2013-2018)
Figure EMEA Cancer Treatment Drugs Sales Market Share by Type (2013-2018)
Table EMEA Cancer Treatment Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
Table EMEA Cancer Treatment Drugs Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Cancer Treatment Drugs by Type in 2017
Table EMEA Cancer Treatment Drugs Sale Price (USD/MT) by Type (2013-2018)
Table EMEA Cancer Treatment Drugs Sales (K MT) and Market Share by Application (2013-2018)
Table EMEA Cancer Treatment Drugs Sales Share by Application (2013-2018)
Figure Sales Market Share of Cancer Treatment Drugs by Application (2013-2018)
Figure EMEA Cancer Treatment Drugs Sales Market Share by Application in 2017
Table EMEA Cancer Treatment Drugs Sales (K MT) and Market Share by Region (2013-2018)
Table EMEA Cancer Treatment Drugs Sales Share by Region (2013-2018)
Figure Sales Market Share of Cancer Treatment Drugs by Region (2013-2018)
Figure EMEA Cancer Treatment Drugs Sales Market Share in 2017
Table EMEA Cancer Treatment Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
Table EMEA Cancer Treatment Drugs Revenue Share by Region (2013-2018)
Figure Revenue Market Share of Cancer Treatment Drugs by Region (2013-2018)
Figure EMEA Cancer Treatment Drugs Revenue Market Share Regions in 2017
Table EMEA Cancer Treatment Drugs Sales Price (USD/MT) by Region (2013-2018)
Figure Europe Cancer Treatment Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure Europe Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Table Europe Cancer Treatment Drugs Sales (K MT) by Type (2013-2018)
Table Europe Cancer Treatment Drugs Market Share by Type (2013-2018)
Figure Europe Cancer Treatment Drugs Market Share by Type in 2017
Table Europe Cancer Treatment Drugs Sales (K MT) by Application (2013-2018)
Table Europe Cancer Treatment Drugs Market Share by Application (2013-2018)
Figure Europe Cancer Treatment Drugs Market Share by Application in 2017
Table Europe Cancer Treatment Drugs Sales (K MT) by Countries (2013-2018)
Table Europe Cancer Treatment Drugs Sales Market Share by Countries (2013-2018)
Figure Europe Cancer Treatment Drugs Sales Market Share by Countries (2013-2018)
Figure Europe Cancer Treatment Drugs Sales Market Share by Countries in 2017
Table Europe Cancer Treatment Drugs Revenue (Million USD) by Countries (2013-2018)
Table Europe Cancer Treatment Drugs Revenue Market Share by Countries (2013-2018)
Figure Europe Cancer Treatment Drugs Revenue Market Share by Countries (2013-2018)
Figure Europe Cancer Treatment Drugs Revenue Market Share by Countries in 2017
Figure Germany Cancer Treatment Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure France Cancer Treatment Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure UK Cancer Treatment Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure Russia Cancer Treatment Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure Italy Cancer Treatment Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure Benelux Cancer Treatment Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure Middle East Cancer Treatment Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure Middle East Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Table Middle East Cancer Treatment Drugs Sales (K MT) by Type (2013-2018)
Table Middle East Cancer Treatment Drugs Market Share by Type (2013-2018)
Figure Middle East Cancer Treatment Drugs Market Share by Type (2013-2018)
Table Middle East Cancer Treatment Drugs Sales (K MT) by Applications (2013-2018)
Table Middle East Cancer Treatment Drugs Market Share by Applications (2013-2018)
Figure Middle East Cancer Treatment Drugs Sales Market Share by Application in 2017
Table Middle East Cancer Treatment Drugs Sales Volume (K MT) by Countries (2013-2018)
Table Middle East Cancer Treatment Drugs Sales Volume Market Share by Countries (2013-2018)
Figure Middle East Cancer Treatment Drugs Sales Volume Market Share by Countries in 2017
Table Middle East Cancer Treatment Drugs Revenue (Million USD) by Countries (2013-2018)
Table Middle East Cancer Treatment Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East Cancer Treatment Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East Cancer Treatment Drugs Revenue Market Share by Countries in 2017
Figure Saudi Arabia Cancer Treatment Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure Israel Cancer Treatment Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure UAE Cancer Treatment Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure Iran Cancer Treatment Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure Africa Cancer Treatment Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure Africa Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Table Africa Cancer Treatment Drugs Sales (K MT) by Type (2013-2018)
Table Africa Cancer Treatment Drugs Sales Market Share by Type (2013-2018)
Figure Africa Cancer Treatment Drugs Sales Market Share by Type (2013-2018)
Figure Africa Cancer Treatment Drugs Sales Market Share by Type in 2017
Table Africa Cancer Treatment Drugs Sales (K MT) by Application (2013-2018)
Table Africa Cancer Treatment Drugs Sales Market Share by Application (2013-2018)
Figure Africa Cancer Treatment Drugs Sales Market Share by Application (2013-2018)
Table Africa Cancer Treatment Drugs Sales Volume (K MT) by Countries (2013-2018)
Table Africa Cancer Treatment Drugs Sales Market Share by Countries (2013-2018)
Figure Africa Cancer Treatment Drugs Sales Market Share by Countries (2013-2018)
Figure Africa Cancer Treatment Drugs Sales Market Share by Countries in 2017
Table Africa Cancer Treatment Drugs Revenue (Million USD) by Countries (2013-2018)
Table Africa Cancer Treatment Drugs Revenue Market Share by Countries (2013-2018)
Figure Africa Cancer Treatment Drugs Revenue Market Share by Countries (2013-2018)
Figure Africa Cancer Treatment Drugs Revenue Market Share by Countries in 2017
Figure South Africa Cancer Treatment Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure Nigeria Cancer Treatment Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure Egypt Cancer Treatment Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure Algeria Cancer Treatment Drugs Sales (K MT) and Growth Rate (2013-2018)
Table Roche (Switzerland) Cancer Treatment Drugs Basic Information List
Table Roche (Switzerland) Cancer Treatment Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Roche (Switzerland) Cancer Treatment Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure Roche (Switzerland) Cancer Treatment Drugs Sales Market Share in EMEA (2013-2018)
Figure Roche (Switzerland) Cancer Treatment Drugs Revenue Market Share in EMEA (2013-2018)
Table Novartis (Switzerland) Cancer Treatment Drugs Basic Information List
Table Novartis (Switzerland) Cancer Treatment Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Novartis (Switzerland) Cancer Treatment Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure Novartis (Switzerland) Cancer Treatment Drugs Sales Market Share in EMEA (2013-2018)
Figure Novartis (Switzerland) Cancer Treatment Drugs Revenue Market Share in EMEA (2013-2018)
Table Celgene (U.S.) Cancer Treatment Drugs Basic Information List
Table Celgene (U.S.) Cancer Treatment Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Celgene (U.S.) Cancer Treatment Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure Celgene (U.S.) Cancer Treatment Drugs Sales Market Share in EMEA (2013-2018)
Figure Celgene (U.S.) Cancer Treatment Drugs Revenue Market Share in EMEA (2013-2018)
Table Amgen (U.S.) Cancer Treatment Drugs Basic Information List
Table Amgen (U.S.) Cancer Treatment Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Amgen (U.S.) Cancer Treatment Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure Amgen (U.S.) Cancer Treatment Drugs Sales Market Share in EMEA (2013-2018)
Figure Amgen (U.S.) Cancer Treatment Drugs Revenue Market Share in EMEA (2013-2018)
Table Johnson & Johnson (U.S.) Cancer Treatment Drugs Basic Information List
Table Johnson & Johnson (U.S.) Cancer Treatment Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Johnson & Johnson (U.S.) Cancer Treatment Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure Johnson & Johnson (U.S.) Cancer Treatment Drugs Sales Market Share in EMEA (2013-2018)
Figure Johnson & Johnson (U.S.) Cancer Treatment Drugs Revenue Market Share in EMEA (2013-2018)
Table Bristol-Myers Squibb (U.S.) Cancer Treatment Drugs Basic Information List
Table Bristol-Myers Squibb (U.S.) Cancer Treatment Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Bristol-Myers Squibb (U.S.) Cancer Treatment Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure Bristol-Myers Squibb (U.S.) Cancer Treatment Drugs Sales Market Share in EMEA (2013-2018)
Figure Bristol-Myers Squibb (U.S.) Cancer Treatment Drugs Revenue Market Share in EMEA (2013-2018)
Table Takeda (Japan) Cancer Treatment Drugs Basic Information List
Table Takeda (Japan) Cancer Treatment Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Takeda (Japan) Cancer Treatment Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure Takeda (Japan) Cancer Treatment Drugs Sales Market Share in EMEA (2013-2018)
Figure Takeda (Japan) Cancer Treatment Drugs Revenue Market Share in EMEA (2013-2018)
Table Eli Lilly (U.S.) Cancer Treatment Drugs Basic Information List
Table Eli Lilly (U.S.) Cancer Treatment Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Eli Lilly (U.S.) Cancer Treatment Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure Eli Lilly (U.S.) Cancer Treatment Drugs Sales Market Share in EMEA (2013-2018)
Figure Eli Lilly (U.S.) Cancer Treatment Drugs Revenue Market Share in EMEA (2013-2018)
Table Pfizer (U.S.) Cancer Treatment Drugs Basic Information List
Table Pfizer (U.S.) Cancer Treatment Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Pfizer (U.S.) Cancer Treatment Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure Pfizer (U.S.) Cancer Treatment Drugs Sales Market Share in EMEA (2013-2018)
Figure Pfizer (U.S.) Cancer Treatment Drugs Revenue Market Share in EMEA (2013-2018)
Table AstraZeneca (Sweden) Cancer Treatment Drugs Basic Information List
Table AstraZeneca (Sweden) Cancer Treatment Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure AstraZeneca (Sweden) Cancer Treatment Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure AstraZeneca (Sweden) Cancer Treatment Drugs Sales Market Share in EMEA (2013-2018)
Figure AstraZeneca (Sweden) Cancer Treatment Drugs Revenue Market Share in EMEA (2013-2018)
Table Astellas (Japan) Cancer Treatment Drugs Basic Information List
Table Sanofi (France) Cancer Treatment Drugs Basic Information List
Table Bayer (Germany) Cancer Treatment Drugs Basic Information List
Table Merck & Co. (U.S.) Cancer Treatment Drugs Basic Information List
Table Biogen Idec (U.S.) Cancer Treatment Drugs Basic Information List
Table Kyowa Hakko Kirin (Japan) Cancer Treatment Drugs Basic Information List
Table Otsuka (Japan) Cancer Treatment Drugs Basic Information List
Table Teva (Israel) Cancer Treatment Drugs Basic Information List
Table Eisai (Japan) Cancer Treatment Drugs Basic Information List
Table Merck KGaA (Germany) Cancer Treatment Drugs Basic Information List
Table Ipsen (France) Cancer Treatment Drugs Basic Information List
Table AbbVie (U.S.) Cancer Treatment Drugs Basic Information List
Table Gilead Sciences (U.S.) Cancer Treatment Drugs Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Treatment Drugs
Figure Manufacturing Process Analysis of Cancer Treatment Drugs
Figure Cancer Treatment Drugs Industrial Chain Analysis
Table Raw Materials Sources of Cancer Treatment Drugs Major Manufacturers in 2017
Table Major Buyers of Cancer Treatment Drugs
Table Distributors/Traders List
Figure EMEA Cancer Treatment Drugs Sales (K MT) and Growth Rate Forecast (2018-2025)
Figure EMEA Cancer Treatment Drugs Revenue and Growth Rate Forecast (2018-2025)
Figure EMEA Cancer Treatment Drugs Price (USD/MT) and Trend Forecast (2018-2025)
Table EMEA Cancer Treatment Drugs Sales (K MT) Forecast by Region (2018-2025)
Figure EMEA Cancer Treatment Drugs Sales Market Share Forecast by Region (2018-2025)
Table EMEA Cancer Treatment Drugs Revenue (Million USD) Forecast by Region (2018-2025)
Figure EMEA Cancer Treatment Drugs Revenue Market Share Forecast by Region (2018-2025)
Table Europe Cancer Treatment Drugs Sales (K MT) Forecast by Countries (2018-2025)
Figure Europe Cancer Treatment Drugs Sales Market Share Forecast by Countries (2018-2025)
Table Europe Cancer Treatment Drugs Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Europe Cancer Treatment Drugs Revenue Market Share Forecast by Countries (2018-2025)
Table Middle East Cancer Treatment Drugs Sales (K MT) Forecast by Countries (2018-2025)
Figure Middle East Cancer Treatment Drugs Sales Market Share Forecast by Countries (2018-2025)
Table Middle East Cancer Treatment Drugs Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Middle East Cancer Treatment Drugs Revenue Market Share Forecast by Countries (2018-2025)
Table Africa Cancer Treatment Drugs Sales (K MT) Forecast by Countries (2018-2025)
Figure Africa Cancer Treatment Drugs Sales Market Share Forecast by Countries (2018-2025)
Table Africa Cancer Treatment Drugs Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Africa Cancer Treatment Drugs Revenue Market Share Forecast by Countries (2018-2025)
Table EMEA Cancer Treatment Drugs Sales (K MT) Forecast by Type (2018-2025)
Figure EMEA Cancer Treatment Drugs Sales Market Share Forecast by Type (2018-2025)
Table EMEA Cancer Treatment Drugs Sales (K MT) Forecast by Application (2018-2025)
Figure EMEA Cancer Treatment Drugs Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources